West Pharmaceutical (WST) Tops Q4 EPS by 5c; Issues Strong FY13 Outlook

February 21, 2013 7:27 AM EST Send to a Friend
Get Alerts WST Hot Sheet
Trade WST Now!
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q4 EPS of $0.61, $0.05 better than the analyst estimate of $0.56. Revenue for the quarter came in at $321.5 million versus the consensus estimate of $318.75 million.

West Pharmaceutical Services, Inc. sees FY2013 EPS of $2.97-3.17, versus the consensus of $3.00. West Pharmaceutical Services, Inc. sees FY2013 revenue of $1.36-1.40 billion, versus the consensus of $1.32 billion.

For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment